Harmony Biosciences has released information about their PWS Phase 2 clinical trial where they will be studying "the safety and impact of an investigational medication on excessive daytime sleepiness, cognition, and behavioral function in people with PWS." Harmony Biosciences is currently looking for individuals with PWS between the ages of 6-65 to enroll in this clinical trial. Learn how to participate by clicking the button or image below.
Carrie LarsenView posts by Carrie Larsen
Calling All New Englanders! Support PWSA | USA at the 14th Annual Hunter Lens Golf Tournament
September 22, 2023
Transformative Tales: Empowering Families Dealing with Prader-Willi Syndrome Through Food Security
September 7, 2023
Neuren Pharmaceuticals is Happy to Announce the First Site Participating in Their Phase II, Open Label, PWS Study (Neu-2591-PWS-001) is Now Open for Screening!
September 1, 2023